Expert Video - How do my genetic mutations influence MDS risk?
Prof. Valeria Santini, MD, an expert on MDS from the University of Florence, describes how the specific genetic mutations you have can tell your doctor how likely your MDS is to transform into leukemia and how the disease will probably respond to treatment. Along with platelet count and white blood cell count, gene mutations and chromosome abnormalities help your doctor understand whether your MDS is high or low risk and to make treatment decisions.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.